SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 297 filers reported holding SEATTLE GENETICS INC in Q2 2018. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $813,000 | -86.6% | 4,155 | -92.2% | 0.01% | -94.1% |
Q4 2019 | $6,063,000 | +769.9% | 53,062 | +457.7% | 0.12% | +461.9% |
Q1 2019 | $697,000 | -89.6% | 9,514 | -90.6% | 0.02% | -88.3% |
Q2 2018 | $6,732,000 | -18.6% | 101,405 | -35.3% | 0.18% | +1.1% |
Q4 2016 | $8,267,000 | +716.1% | 156,655 | +735.4% | 0.18% | +709.1% |
Q3 2016 | $1,013,000 | -23.1% | 18,753 | -31.2% | 0.02% | -67.2% |
Q2 2015 | $1,318,000 | – | 27,241 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Parametrica Management Ltd | 3,581 | $248,000 | 42.18% |
Baker Brothers Advisors | 50,057,277 | $3,464,464,000 | 23.54% |
Lagoda Investment Management, L.P. | 76,073 | $5,265,000 | 6.10% |
Matrix Capital Management Company, LP | 3,141,852 | $217,448,000 | 4.02% |
DOMINI IMPACT INVESTMENTS LLC | 3,111 | $215,000 | 2.98% |
Opus Point Partners Management, LLC | 17,901 | $1,239,000 | 1.83% |
EMORY UNIVERSITY | 33,593 | $2,325,000 | 1.64% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,215,000 | 1.56% |
Capital International Sarl | 130,400 | $9,025,000 | 1.26% |
CAPITAL GUARDIAN TRUST CO | 1,303,961 | $90,147,000 | 1.21% |